High dose influenza vaccine for adults a review of clinical effectiveness, cost-effectiveness, and guidelines

The purpose of this review is to evaluate the comparative clinical evidence of high-dose influenza vaccination compared with standard-dose (and double-dose) influenza vaccine or placebo. Additionally, the comparative cost effectiveness and evidence-based guidelines were analyzed to facilitate and su...

Full description

Bibliographic Details
Main Authors: Wells, Charlotte, Grobelna, Aleksandra (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa (ON) CADTH 2019, January 8, 2019
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01881nam a2200385 u 4500
001 EB001888686
003 EBX01000000000000001052047
005 00000000000000.0
007 tu|||||||||||||||||||||
008 200106 r ||| eng
100 1 |a Wells, Charlotte 
245 0 0 |a High dose influenza vaccine for adults  |h Elektronische Ressource  |b a review of clinical effectiveness, cost-effectiveness, and guidelines  |c Charlotte Wells, Aleksandra Grobelna 
250 |a Version 1.0 
260 |a Ottawa (ON)  |b CADTH  |c 2019, January 8, 2019 
300 |a 1 PDF file (45 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
653 |a Comparative Effectiveness Research 
653 |a Canada 
653 |a Influenza Vaccines / economics 
653 |a Cost-Benefit Analysis 
653 |a Aged 
653 |a Treatment Outcome 
653 |a Influenza, Human / drug therapy 
653 |a Influenza Vaccines / therapeutic use 
653 |a Guidelines as Topic 
700 1 |a Grobelna, Aleksandra  |e [author] 
710 2 |a Canadian Agency for Drugs and Technologies in Health 
710 2 |a Canadian Agency for Drugs and Technologies in Health  |b Rapid Response Service 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a CADTH rapid response report: summary with critical appraisal 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK541617  |3 Volltext  |n NLM Bookshelf Books  |3 Volltext 
082 0 |a 140 
082 0 |a 330 
520 |a The purpose of this review is to evaluate the comparative clinical evidence of high-dose influenza vaccination compared with standard-dose (and double-dose) influenza vaccine or placebo. Additionally, the comparative cost effectiveness and evidence-based guidelines were analyzed to facilitate and support decision making with regards to high-dose influenza vaccine